Judith Behnke1, Brigitte Lemyre, Christoph Czernik, Klaus-Peter Zimmer, Harald Ehrhardt, Markus Waitz. 1. Department of General Pediatrics & Neonatology, Center for Pediatrics and Youth Medicine, Justus Liebig University of Giessen; Division of Neonatology, Children's Hospital of Eastern Ontario, Ottawa, Canada; Department of Neonatology, Charité-Universitätsmedizin Berlin, Berlin; Member of the German Lung Research Center (DZL), Giessen.
Abstract
BACKGROUND: Invasive mechanical ventilation (IMV) has been replaced by early continuous positive airway pressure (CPAP) in the treatment of respiratory distress syndrome (RDS) in preterm infants aiming to reduce the rate of bronchopulmonary dysplasia (BPD). Subsequently, modern non-invasive ventilation strategies (NIV) were introduced into clinical practice with limited evidence of effects on pulmonary and neurodevelopmental outcomes. METHODS: We performed a selective literature search in PubMed including randomized controlled trials (RCT) (n ≥ 200) and meta-analyses published in the field of NIV in neonatology and follow-up studies focusing on long term pulmonary and neurodevelopmental outcomes. RESULTS: Individual studies do not show a significant risk reduction for the combined endpoint death or BPD in preterm infants caused by early CPAP in RDS when compared to primary intubation. One meta-analysis comparing four studies found CPAP significantly reduces the risk of BPD or death (relative risk: 0.91; 95% confidence interval [0.84;0.99]). Nasal intermittent positive pressure ventilation (NIPPV) as a primary ventilation strategy reduces the rate of intubations in infants with RDS (RR: 0.78 [0.64;0.94]) when compared to CPAP but does not affect the rate of BPD (RR: 0.78 [0.58;1.06]). CONCLUSION: Early CPAP reduces the need for IMV and the risk of BPD or death in preterm infants with RDS. NIPPV may offer advantages over CPAP regarding intubation rates. Networking-based follow-up programs are required to assess the effect of NIV on long term pulmonary and neurodevelopmental outcomes.
BACKGROUND: Invasive mechanical ventilation (IMV) has been replaced by early continuous positive airway pressure (CPAP) in the treatment of respiratory distress syndrome (RDS) in preterm infants aiming to reduce the rate of bronchopulmonary dysplasia (BPD). Subsequently, modern non-invasive ventilation strategies (NIV) were introduced into clinical practice with limited evidence of effects on pulmonary and neurodevelopmental outcomes. METHODS: We performed a selective literature search in PubMed including randomized controlled trials (RCT) (n ≥ 200) and meta-analyses published in the field of NIV in neonatology and follow-up studies focusing on long term pulmonary and neurodevelopmental outcomes. RESULTS: Individual studies do not show a significant risk reduction for the combined endpoint death or BPD in preterm infants caused by early CPAP in RDS when compared to primary intubation. One meta-analysis comparing four studies found CPAP significantly reduces the risk of BPD or death (relative risk: 0.91; 95% confidence interval [0.84;0.99]). Nasal intermittent positive pressure ventilation (NIPPV) as a primary ventilation strategy reduces the rate of intubations in infants with RDS (RR: 0.78 [0.64;0.94]) when compared to CPAP but does not affect the rate of BPD (RR: 0.78 [0.58;1.06]). CONCLUSION: Early CPAP reduces the need for IMV and the risk of BPD or death in preterm infants with RDS. NIPPV may offer advantages over CPAP regarding intubation rates. Networking-based follow-up programs are required to assess the effect of NIV on long term pulmonary and neurodevelopmental outcomes.
Authors: Richard A Ehrenkranz; Michele C Walsh; Betty R Vohr; Alan H Jobe; Linda L Wright; Avroy A Fanaroff; Lisa A Wrage; Kenneth Poole Journal: Pediatrics Date: 2005-12 Impact factor: 7.124
Authors: Colin J Morley; Peter G Davis; Lex W Doyle; Luc P Brion; Jean-Michel Hascoet; John B Carlin Journal: N Engl J Med Date: 2008-02-14 Impact factor: 91.245
Authors: Andrea L Lampland; Patricia A Meyers; Cathy T Worwa; Elizabeth C Swanson; Mark C Mammel Journal: Crit Care Med Date: 2008-01 Impact factor: 7.598
Authors: Mario Augusto Rojas; Juan Manuel Lozano; Maria Ximena Rojas; Matthew Laughon; Carl Lewis Bose; Martin Alonso Rondon; Laura Charry; Jaime Alberto Bastidas; Luis Alfonso Perez; Catherine Rojas; Oscar Ovalle; Luz Astrid Celis; Jorge Garcia-Harker; Martha Lucia Jaramillo Journal: Pediatrics Date: 2009-01 Impact factor: 7.124
Authors: Markus Waitz; Corinna Engel; Rolf Schloesser; Ulrich Rochwalsky; Sascha Meyer; Alexander Larsen; Paul Hoffmann; Michael Zemlin; Bettina Bohnhorst; Corinna Peter; Marc Hoppenz; Thomas Pabst; Klaus-Peter Zimmer; Axel R Franz; Christoph Haertel; Eric Frieauff; Julia Sandkötter; Katja Masjosthusmann; Philipp Deindl; Dominique Singer; Melanie Heidkamp; Annesuse Schmidt; Harald Ehrhardt Journal: Trials Date: 2020-10-01 Impact factor: 2.279